Skip to main content
. Author manuscript; available in PMC: 2009 Jan 28.
Published in final edited form as: Diabetes Care. 2000 Aug;23(8):1084–1091. doi: 10.2337/diacare.23.8.1084

Table 5.

OR of ≥3-step retinopathy progression from baseline level during each pregnancy state

Intensive treatment*
Conventional treatment
Pregnancy state OR 95% CI P OR 95% CI P
Changed to intensive therapy
 before conception but not yet
pregnant
- - - 1.56 0.53–4.56 NS
Pregnant vs. not pregnant 1.37 0.56–3.33 NS 2.90 1.45–5.82 0.003
 First trimester - - - 1.93 0.57–6.61 NS
 Second trimester - - - 4.26 2.05–8.88 <0.001
 Third trimester - - - 2.56 0.91–7.26 NS
After pregnancy
 0–6 months 1.54 0.81–2.95 NS 3.16 1.61–6.19 <0.001
 6–12 months 1.38 0.65–2.90 NS 2.87 1.37–6.01 0.005
 >12 months 0.65 0.31–1.36 NS 1.19 0.60–2.40 NS

Data are adjusted for time in study, baseline retinopathy status, age, duration of diabetes, screening HbA1c, history of pregnancy, prior # DCCT, and current mean HbA1c.

*

OR versus not pregnant

OR versus not pregnant and not changed to intensive therapy in preparation for conception

unadjusted for first, second, or third trimester.